Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Influenza

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 135 articles: HTML format

Single Articles

April 2025
1. UYEKI TM, Dugan VG, Daskalakis DC
   Baloxavir Treatment to Reduce Influenza Virus Transmission.
   N Engl J Med. 2025;392:1652-1654.
   PubMed    
   
   
   
2. MONTO AS, Kuhlbusch K, Bernasconi C, Cao B, et al
   Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.
   N Engl J Med. 2025;392:1582-1593.
   PubMed     Abstract available
   
   
   February 2025
3. WANG JJ, Warkentin TE, Schonborn L, Wheeler MB, et al
   VITT-like Monoclonal Gammopathy of Thrombotic Significance.
   N Engl J Med. 2025 Feb 12. doi: 10.1056/NEJMoa2415930.
   PubMed     Abstract available
   
   
   January 2025
4. HALL VG, Smibert OC, Sullivan SG, Lim C, et al
   Influenza Vaccination Strategies in Patients with Hematologic Cancer.
   N Engl J Med. 2025;392:306-308.
   PubMed    
   
   
   December 2024
5. GARG S, Reinhart K, Couture A, Kniss K, et al
   Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans.
   N Engl J Med. 2024 Dec 31. doi: 10.1056/NEJMoa2414610.
   PubMed     Abstract available
   
   
   
6. JASSEM AN, Roberts A, Tyson J, Zlosnik JEA, et al
   Critical Illness in an Adolescent with Influenza A(H5N1) Virus Infection.
   N Engl J Med. 2024 Dec 31. doi: 10.1056/NEJMc2415890.
   PubMed    
   
   
   October 2024
7. BLENDON RJ, Blumenthal D, Glied S, Sommers BD, et al
   Critical Health Care Challenges for the Next U.S. President.
   N Engl J Med. 2024;391:e36.
   PubMed    
   
   
   September 2024
8. WALSH EE
   Creeping toward Effective Antiviral Agents for RSV Infection.
   N Engl J Med. 2024;391:1155-1156.
   PubMed    
   
   
   
9. ZHAO S, Shang Y, Yin Y, Zou Y, et al
   Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection.
   N Engl J Med. 2024;391:1096-1107.
   PubMed     Abstract available
   
   
   
10. 
    What Exactly Is Long Covid?: ITT Episode 37.
    N Engl J Med. 2024;391:e17.
    PubMed    
    
    
    
11. TISZA MJ, Hanson BM, Clark JR, Wang L, et al
    Sequencing-Based Detection of Avian Influenza A(H5N1) Virus in Wastewater in Ten Cities.
    N Engl J Med. 2024 Sep 11. doi: 10.1056/NEJMc2405937.
    PubMed    
    
    
    
12. ROTTER LK
    "Do You Feel Safe at Home?".
    N Engl J Med. 2024;391:785-787.
    PubMed    
    
    
    
13. WALENSKY RP, Baggett MV, Tran KM, Shepard JO, et al
    Case 27-2024: A 24-Year-Old Man with Pain and Dyspnea.
    N Engl J Med. 2024;391:845-852.
    PubMed    
    
    
    August 2024
14. DAVIS E, Mayer S, Pacilli M
    Academic Medical Center-Public Health Partnerships for Outbreak Response - Collaborating with Underresourced Communities.
    N Engl J Med. 2024;391:679-681.
    PubMed    
    
    
    
15. HAYES C
    In Pursuit of Polka Dots.
    N Engl J Med. 2024;391:582-583.
    PubMed    
    
    
    
16. CANDRIAN C, Weissman JS, Tjia J
    SOGI Data Collection - Proceeding, but with Caution.
    N Engl J Med. 2024;391:580-581.
    PubMed    
    
    
    
17. HALABI S, O'Hara GL
    Preparing for the Next Pandemic - Expanding and Coordinating Global Regulatory Capacity.
    N Engl J Med. 2024;391:484-487.
    PubMed    
    
    
    
18. MAKARI GJ, Friedman RA
    Collective Trauma and Commemoration - A Moment of Silence, Please.
    N Engl J Med. 2024;391:487-489.
    PubMed    
    
    
    
19. MIN J
    Studies of Exagamglogene Autotemcel - Age and Place.
    N Engl J Med. 2024;391:571-572.
    PubMed    
    
    
    
20. MORSE J, Coyle J, Mikesell L, Stoddard B, et al
    Influenza A(H5N1) Virus Infection in Two Dairy Farm Workers in Michigan.
    N Engl J Med. 2024 Aug 7. doi: 10.1056/NEJMc2407264.
    PubMed    
    
    
    
21. HAMMOND J, Fountaine RJ, Bao W
    Nirmatrelvir for Adult Outpatients with Covid-19. Reply.
    N Engl J Med. 2024;391:478-479.
    PubMed    
    
    
    
22. SHANG L, Wang Y, Cao B
    Nirmatrelvir for Adult Outpatients with Covid-19.
    N Engl J Med. 2024;391:477-478.
    PubMed    
    
    
    
23. BLAIS JE
    Nirmatrelvir for Adult Outpatients with Covid-19.
    N Engl J Med. 2024;391:477.
    PubMed    
    
    
    
24. SHAN D, Zhang G, Du Z
    Nirmatrelvir for Adult Outpatients with Covid-19.
    N Engl J Med. 2024;391:477.
    PubMed    
    
    
    July 2024
25. SINHA MS, Parmet WE, Gonsalves GS
    Deja Vu All Over Again - Refusing to Learn the Lessons of Covid-19.
    N Engl J Med. 2024 Jul 24. doi: 10.1056/NEJMp2406427.
    PubMed    
    
    
    
26. HAMMOND J, Yunis C, Fountaine RJ, Luscan G, et al
    Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.
    N Engl J Med. 2024;391:224-234.
    PubMed     Abstract available
    
    
    
27. MEISSNER HC, Kapogiannis BG, Wolfe DN
    Anticipating the Next Pandemic.
    N Engl J Med. 2024;391:196-199.
    PubMed    
    
    
    
28. ROSEN CJ
    Viral Variants, Vaccinations, and Long Covid - New Insights.
    N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMe2407575.
    PubMed    
    
    
    
29. XIE Y, Choi T, Al-Aly Z
    Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras.
    N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMoa2403211.
    PubMed     Abstract available
    
    
    
30. ASSAD Z, Romain AS, Aupiais C, Shum M, et al
    Nirsevimab and Hospitalization for RSV Bronchiolitis.
    N Engl J Med. 2024;391:144-154.
    PubMed     Abstract available
    
    
    June 2024
31. 
    Are We Prepared for Bird Flu?: ITT Episode 32.
    N Engl J Med. 2024;390:e59.
    PubMed    
    
    
    
32. SAMET JH, El-Bassel N, Winhusen TJ, Jackson RD, et al
    Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
    N Engl J Med. 2024 Jun 16. doi: 10.1056/NEJMoa2401177.
    PubMed     Abstract available
    
    
    
33. KAISER F, Morris DH, Wickenhagen A, Mukesh R, et al
    Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63 degrees C and 72 degrees C.
    N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMc2405488.
    PubMed    
    
    
    
34. OWUSU-ANSAH S, Green Rodgers P
    Reviving Hearts - Uniting Communities with Lifesaving Bystander CPR.
    N Engl J Med. 2024;390:2040-2041.
    PubMed    
    
    
    
35. HAMPSHIRE A, Elliott P
    Cognition and Memory after Covid-19 in a Large Community Sample. Reply.
    N Engl J Med. 2024;390:2035.
    PubMed    
    
    
    
36. XU L, Huang X, Li Y
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034-2035.
    PubMed    
    
    
    
37. BUONSENSO D
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034.
    PubMed    
    
    
    May 2024
38. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
    Global Health Law for a Safer and Fairer World.
    N Engl J Med. 2024;390:1925-1931.
    PubMed    
    
    
    
39. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    PubMed    
    
    
    
40. GUAN L, Eisfeld AJ, Pattinson D, Gu C, et al
    Cow's Milk Containing Avian Influenza A(H5N1) Virus - Heat Inactivation and Infectivity in Mice.
    N Engl J Med. 2024 May 24. doi: 10.1056/NEJMc2405495.
    PubMed    
    
    
    
41. RUBIN EJ, Baden LR, Daskalakis D, Marston H, et al
    Audio Interview: Preparing for a Possible Avian Influenza Outbreak.
    N Engl J Med. 2024 May 22. doi: 10.1056/NEJMe2406224.
    PubMed    
    
    
    
42. RUBIN EJ, Baden LR, Marrazzo J, Monto A, et al
    Audio Interview: The Current State of Avian Influenza.
    N Engl J Med. 2024 May 20. doi: 10.1056/NEJMe2406223.
    PubMed    
    
    
    
43. HERBERT C, McManus DD, Soni A
    False Positive Covid-19 Rapid Antigen Tests. Reply.
    N Engl J Med. 2024;390:1836.
    PubMed    
    
    
    
44. YANG C, Espin E, Tebbutt SJ
    False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:1835-1836.
    PubMed    
    
    
    
45. SCHUBACH A, Ricotta D, Kittleson MM
    To Preround or Not to Preround.
    N Engl J Med. 2024;390:1824-1826.
    PubMed    
    
    
    
46. UYEKI TM, Milton S, Abdul Hamid C, Reinoso Webb C, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.
    N Engl J Med. 2024 May 3. doi: 10.1056/NEJMc2405371.
    PubMed    
    
    
    April 2024
47. WANG Y, Hu H, Cao B
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply.
    N Engl J Med. 2024;390:1534-1535.
    PubMed    
    
    
    
48. SELVI-SABATER P, de la Rubia Orti JE, Urbieta-Sanz E
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1534.
    PubMed    
    
    
    
49. MOSER CB, Li JZ, Hughes MD
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1533-1534.
    PubMed    
    
    
    
50. GANDHI RT, Hirsch M
    Treating Acute Covid-19 - Final Chapters Still Unwritten.
    N Engl J Med. 2024;390:1234-1236.
    PubMed    
    
    
    
51. HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
    Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
    N Engl J Med. 2024;390:1186-1195.
    PubMed     Abstract available
    
    
    March 2024
52. HSIAO A, Fireman B, Klein NP
    Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
    N Engl J Med. 2024;390:1156.
    PubMed    
    
    
    
53. WOO EJ, Hulse AN
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155-1156.
    PubMed    
    
    
    
54. HAVIARI S, Massonnaud CR, Dupont A
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155.
    PubMed    
    
    
    
55. DIEUSSAERT I, Hyung Kim J, Luik S, Seidl C, et al
    RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.
    N Engl J Med. 2024;390:1009-1021.
    PubMed     Abstract available
    
    
    February 2024
56. ELLINGJORD-DALE M, Brunvoll SH, Soraas A
    Prospective Memory Assessment before and after Covid-19.
    N Engl J Med. 2024;390:863-865.
    PubMed    
    
    
    
57. AL-ALY Z, Rosen CJ
    Long Covid and Impaired Cognition - More Evidence and More Work to Do.
    N Engl J Med. 2024;390:858-860.
    PubMed    
    
    
    
58. HAMPSHIRE A, Azor A, Atchison C, Trender W, et al
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:806-818.
    PubMed     Abstract available
    
    
    
59. MONTO AS, Zambon M, Weir JP
    The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
    N Engl J Med. 2024 Feb 28. doi: 10.1056/NEJMp2314801.
    PubMed    
    
    
    
60. BENEZECH S, Khoryati L, Belot A
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C. Reply.
    N Engl J Med. 2024;390:771-772.
    PubMed    
    
    
    
61. FRANCO A, Tremoulet A, Burns JC
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
    N Engl J Med. 2024;390:771.
    PubMed    
    
    
    
62. HERBERT C, McManus DD, Soni A
    Persistent False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:764-765.
    PubMed    
    
    
    January 2024
63. MISSET B, Desmecht D, Laterre PF
    Convalescent Plasma for Covid-19-Induced ARDS. Reply.
    N Engl J Med. 2024;390:386.
    PubMed    
    
    
    
64. CASADEVALL A, Shoham S, Pirofski LA
    Convalescent Plasma for Covid-19-Induced ARDS.
    N Engl J Med. 2024;390:385-386.
    PubMed    
    
    
    
65. SENEFELD JW, Henderson JP, Joyner MJ
    Convalescent Plasma for Covid-19-Induced ARDS.
    N Engl J Med. 2024;390:385.
    PubMed    
    
    
    
66. BORGHESI A, Casanova JL
    Convalescent Plasma for Covid-19-Induced ARDS.
    N Engl J Med. 2024;390:384-385.
    PubMed    
    
    
    
67. CAO B, Wang Y, Lu H, Huang C, et al
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:230-241.
    PubMed     Abstract available
    
    
    December 2023
68. HALASA NB
    RSV Prevention - Breakthroughs and Challenges.
    N Engl J Med. 2023;389:2480-2481.
    PubMed    
    
    
    
69. DRYSDALE SB, Cathie K, Flamein F, Knuf M, et al
    Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.
    N Engl J Med. 2023;389:2425-2435.
    PubMed     Abstract available
    
    
    
70. 
    Covid Update: ITT Episode 23.
    N Engl J Med. 2023;389:e52.
    PubMed    
    
    
    
71. HSIAO A, Yee A, Fireman B, Hansen J, et al
    Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2023;389:2245-2255.
    PubMed     Abstract available
    
    
    
72. COHN AC, Hall AJ
    Continued Progress in the Development of Safe and Effective RSV Immunizations.
    N Engl J Med. 2023;389:2289-2290.
    PubMed    
    
    
    
73. WILSON E, Goswami J, Baqui AH, Doreski PA, et al
    Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
    N Engl J Med. 2023;389:2233-2244.
    PubMed     Abstract available
    
    
    November 2023
74. BENEZECH S, Khoryati L, Cognard J, Netea SA, et al
    Pre-Covid-19, SARS-CoV-2-Negative Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2023;389:2105-2107.
    PubMed    
    
    
    
75. WANG Y, Guo Z, Ye B, Liu L, et al
    Association of SARS-CoV-2 Infection during Early Weeks of Gestation with Situs Inversus.
    N Engl J Med. 2023;389:1722-1724.
    PubMed    
    
    
    October 2023
76. MISSET B, Piagnerelli M, Hoste E, Dardenne N, et al
    Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients.
    N Engl J Med. 2023;389:1590-1600.
    PubMed     Abstract available
    
    
    
77. BLADH O, Greilert-Norin N, Havervall S, Marking U, et al
    Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.
    N Engl J Med. 2023;389:1626-1628.
    PubMed    
    
    
    
78. HILLS TE, Lorenzi E, Berry LR, Shyamsundar M, et al
    Simvastatin in Critically Ill Patients with Covid-19.
    N Engl J Med. 2023 Oct 25. doi: 10.1056/NEJMoa2309995.
    PubMed     Abstract available
    
    
    
79. 
    The Long Haul of Long Covid.
    N Engl J Med. 2023;389:e29.
    PubMed    
    
    
    
80. ABI-RACHED JM, Brandt AM
    Do Pandemics Ever End?
    N Engl J Med. 2023;389:1349-1351.
    PubMed    
    
    
    September 2023
81. BOULWARE DR, Lindsell CJ, Stewart TG, Hernandez AF, et al
    Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
    N Engl J Med. 2023;389:1085-1095.
    PubMed     Abstract available
    
    
    August 2023
82. MURRAY EJ, Cowger TL, Hall KT
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff. Reply.
    N Engl J Med. 2023;389:580.
    PubMed    
    
    
    
83. MARINE JE
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.
    PubMed    
    
    
    
84. LADHANI SN, Andrews N, Ramsay ME
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.
    PubMed    
    
    
    
85. RUSSELL FM, Curtis N, Carlin J
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:578-579.
    PubMed    
    
    
    
86. KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
    SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
    N Engl J Med. 2023;389:474-475.
    PubMed    
    
    
    July 2023
87. BECERRA X, Jha A
    Project NextGen - Defeating SARS-CoV-2 and Preparing for the Next Pandemic.
    N Engl J Med. 2023 Jul 26. doi: 10.1056/NEJMp2307867.
    PubMed    
    
    
    
88. ARBEL R, Sergienko R, Netzer D, Hammerman A, et al
    Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. Reply.
    N Engl J Med. 2023;389:285-286.
    PubMed    
    
    
    
89. HOEG TB, Duriseti R, Prasad V
    Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19.
    N Engl J Med. 2023;389:284-285.
    PubMed    
    
    
    
90. MCCRINDLE BW, Manlhiot C
    More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome. Reply.
    N Engl J Med. 2023;389:287-288.
    PubMed    
    
    
    
91. XIA CY, Niu MM, Hu P
    More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome.
    N Engl J Med. 2023;389:287.
    PubMed    
    
    
    
92. PITTET LF, Messina NL, Curtis N
    BCG to Protect against Covid-19 in Health Care Workers. Reply.
    N Engl J Med. 2023;389:192.
    PubMed    
    
    
    
93. BENN CS, Netea MG, Aaby P
    BCG to Protect against Covid-19 in Health Care Workers.
    N Engl J Med. 2023;389:191-192.
    PubMed    
    
    
    
94. LOPEZ-CAMPOS GH, Valvano MA
    BCG to Protect against Covid-19 in Health Care Workers.
    N Engl J Med. 2023;389:191.
    PubMed    
    
    
    June 2023
95. HALABI S, Wilder R, Gostin LO, Hurtado ML, et al
    Sharing Pathogen Genomic Sequence Data - Toward Effective Pandemic Prevention, Preparedness, and Response.
    N Engl J Med. 2023;388:2401-2404.
    PubMed    
    
    
    
96. CAO Z, Gao Y, Zhao R
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. Reply.
    N Engl J Med. 2023;388:2396-2397.
    PubMed    
    
    
    
97. LI Y
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2396.
    PubMed    
    
    
    
98. EDWARDS JL
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395-2396.
    PubMed    
    
    
    
99. BERGMANN F, Jorda A, Zeitlinger M
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395.
    PubMed    
    
    
    
100. LIN DY, Fleming TR
     VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
     N Engl J Med. 2023;388:2395.
     PubMed    
     
     
     
101. MCGARRY BE, Gandhi AD, Barnett ML
     Covid-19 Surveillance Testing in Nursing Homes. Reply.
     N Engl J Med. 2023;388:2207-2208.
     PubMed    
     
     
     
102. STALL NM, Kain DC, Johnstone J
     Covid-19 Surveillance Testing in Nursing Homes.
     N Engl J Med. 2023;388:2207.
     PubMed    
     
     
     
103. DORFMAN D, Berger Z
     Approving Workplace Accommodations for Patients with Long Covid - Advice for Clinicians.
     N Engl J Med. 2023;388:2115-2117.
     PubMed    
     
     
     
104. NIKOLICH JZ, Rosen CJ
     Toward Comprehensive Care for Long Covid.
     N Engl J Med. 2023;388:2113-2115.
     PubMed    
     
     
     
105. GOSTIN LO, Gronvall GK
     The Origins of Covid-19 - Why It Matters (and Why It Doesn't).
     N Engl J Med. 2023 Jun 7. doi: 10.1056/NEJMp2305081.
     PubMed    
     
     
     
106. TSUBOI M, Herbst RS, John T, Kato T, et al
     Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
     N Engl J Med. 2023 Jun 4. doi: 10.1056/NEJMoa2304594.
     PubMed     Abstract available
     
     
     
107. REIS G, Mills EJ, Glenn JS
     Pegylated Interferon Lambda for Covid-19. Reply.
     N Engl J Med. 2023;388:2108.
     PubMed    
     
     
     
108. WANG M, Tang L, Huang L
     Pegylated Interferon Lambda for Covid-19.
     N Engl J Med. 2023;388:2107-2108.
     PubMed    
     
     
     
109. ANDREAKOS E, Tsiodras S
     Pegylated Interferon Lambda for Covid-19.
     N Engl J Med. 2023;388:2107.
     PubMed    
     
     
     May 2023
110. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: The Lasting Effects of Covid-19.
     N Engl J Med. 2023;388:e76.
     PubMed    
     
     
     
111. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Ending the Covid-19 Emergency.
     N Engl J Med. 2023;388:e72.
     PubMed    
     
     
     
112. LISCO A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al
     Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
     N Engl J Med. 2023;388:1680-1691.
     PubMed     Abstract available
     
     
     April 2023
113. PITTET LF, Messina NL, Orsini F, Moore CL, et al
     Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
     N Engl J Med. 2023;388:1582-1596.
     PubMed     Abstract available
     
     
     
114. KARRON RA
     RSV Illness in the Young and the Old - The Beginning of the End?
     N Engl J Med. 2023;388:1522-1524.
     PubMed    
     
     
     
115. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: When to Get a Second Covid-19 Booster Shot.
     N Engl J Med. 2023;388:e64.
     PubMed    
     
     
     
116. ADAMS G, Moreno GK, Petros BA, Uddin R, et al
     Viral Lineages in the 2022 RSV Surge in the United States.
     N Engl J Med. 2023;388:1335-1337.
     PubMed    
     
     
     
117. KAMPMANN B, Madhi SA, Munjal I, Simoes EAF, et al
     Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
     N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2216480.
     PubMed     Abstract available
     
     
     
118. MULLER WJ, Madhi SA, Seoane Nunez B, Baca Cots M, et al
     Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
     N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMc2214773.
     PubMed    
     
     
     
119. WALSH EE, Perez Marc G, Zareba AM, Falsey AR, et al
     Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
     N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2213836.
     PubMed     Abstract available
     
     
     March 2023
120. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Ending the Covid-19 Public Health Emergency.
     N Engl J Med. 2023;388:e53.
     PubMed    
     
     
     
121. JABAGI MJ, Bertrand M, Botton J, Le Vu S, et al
     Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
     N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134.
     PubMed    
     
     
     
122. NEUZIL KM
     An mRNA Influenza Vaccine - Could It Deliver?
     N Engl J Med. 2023;388:1139-1141.
     PubMed    
     
     
     
123. MCGARRY BE, Gandhi AD, Barnett ML
     Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes.
     N Engl J Med. 2023;388:1101-1110.
     PubMed     Abstract available
     
     
     
124. MCCRINDLE BW, Harahsheh AS, Handoko R, Raghuveer G, et al
     SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children.
     N Engl J Med. 2023 Mar 22. doi: 10.1056/NEJMc2215074.
     PubMed    
     
     
     
125. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: The Future of Covid-19 Research.
     N Engl J Med. 2023;388:e39.
     PubMed    
     
     
     
126. MANSOUR MK, King JD, Chen ST, Fishman JA, et al
     Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.
     N Engl J Med. 2023;388:926-937.
     PubMed    
     
     
     
127. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: The Path Forward for Covid-19 Therapeutics.
     N Engl J Med. 2023;388:e36.
     PubMed    
     
     
     
128. OFFIT PA
     Bivalent Covid-19 Vaccines. Reply.
     N Engl J Med. 2023;388:10.
     PubMed    
     
     
     
129. MARKS PW, Califf RM
     Bivalent Covid-19 Vaccines.
     N Engl J Med. 2023;388:10.
     PubMed    
     
     
     
130. LI D, Duan M, Wang X, Gao P, et al
     Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines.
     N Engl J Med. 2023 Mar 1. doi: 10.1056/NEJMc2216233.
     PubMed    
     
     
     February 2023
131. HUTH L, Schafer L, Almanzar G, Lupoli G, et al
     Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis.
     N Engl J Med. 2023 Feb 15. doi: 10.1056/NEJMc2216309.
     PubMed    
     
     
     January 2023
132. ZOU J, Kurhade C, Patel S, Kitchin N, et al
     Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine.
     N Engl J Med. 2023 Jan 25. doi: 10.1056/NEJMc2214916.
     PubMed    
     
     
     September 2021
133. AMIT S, Gonen T, Regev-Yochay G
     Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.
     N Engl J Med. 2021;385.
     PubMed    
     
     
     
134. JUNG J, Sung H, Kim SH
     Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
     N Engl J Med. 2021;385.
     PubMed    
     
     
     
135. JONES DS, Podolsky SH
     Mask Wars.
     N Engl J Med. 2021;385:1159-1161.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.